FDA Seeks Comment on Regulation Changes for “Meaningful Burden Reduction”

Implementing an executive order titled “Reducing Regulation and Controlling Regulatory Costs,” the U.S. Food and Drug Administration (FDA) has opened a comment period to identify “existing regulations and related paperwork requirements that could be modified, repealed, or replaced, consistent with the law, to achieve meaningful burden reduction while allowing us to achieve our public health mission and fulfill statutory obligations.” FDA will accept comments related to “general regulatory and information collection requirements that affect multiple FDA Centers and/or Offices” and “products regulated by the Center for Food Safety and Applied Nutrition” until December 7, 2017.